Skip to content

Opening book details…

Can I read Nivolumab: Type 1 diabetes mellitus, interstitial pneumonitis and elevated liver enzymes: 3 case report on EtoBox?

Nivolumab: Type 1 diabetes mellitus, interstitial pneumonitis and elevated liver enzymes: 3 case report is a Medicine article available to read on EtoBox.

What is Nivolumab: Type 1 diabetes mellitus, interstitial pneumonitis and elevated liver enzymes: 3 case report about?

## Type 1 diabetes mellitus, interstitial pneumonitis and elevated liver enzymes: 3 case report In a retrospective study of 34 patients, a 72-year-old man, a 65-year-old man and a 53-year-old man were described, who developed type 1 diabetes mellitus, interstitial pneumonitis or elevated liver enzymes during treatment with nivolumab for renal cell carcinoma (RCC). Case 1: A 72-year-old man, who had undergone left radical nephrectomy at the age of 65 years, was diagnosed with clearcell RCC based on pathological findings. However, six years after surgery, multiple lung metastases was observed. Hence, he received treatment with interferon alpha, following which relapse was observed. Further, his treatment was changed to interleukin-2, sorafenib and axitinib. But, progression of disease was observed after each treatment. Nine years after the administration of his first systemic therapy, he was started on nivolumab therapy. Following the treatment with nivolumab, partial response was observed. After the 14 cycles of nivolumab, he was diagnosed with type 1 diabetes mellitus, which was thought to be related to the nivolumab therapy. Nivolumab was discontinued, following which disease prog

Who reads Nivolumab: Type 1 diabetes mellitus, interstitial pneumonitis and elevated liver enzymes: 3 case report?

It is typically read by researchers, students, and practitioners in Medicine.

Publisher
Adis International Limited (now part of Wolters Kluwer Health); Springer-Verlag; Springer Science and Business Media LLC (ISSN 0114-9954)
Published
2018
Language
EN
Field
Medicine (Health Sciences)